Jump to content
  • entries
  • comments
  • views

On The Difficulties Of Conducting Medical Marijuana Research



Though there are currently 18 medical marijuana states, and marijuana possession has been decriminalized in Colorado and Washington, many hurdles still exist when it comes to researching the drug's medicinal benefits. In 1970, under the Nixon administration, Marijuana was classified as a schedule 1 controlled substance, right along with heroine and above cocaine. The schedule 1 label, as determined by the DEA, means that marijuana:

(A) has high potential for abuse.

(B) The drug or other substance has no currently accepted medical use in treatment in the United States.

© There is a lack of accepted safety for use of the drug or other substance under medical supervision.


Though the country has moved beyond Nixon, the policies that his administration implemented as part of the Comprehensive Drug Abuse Prevention and Control Act of 1970 were a continuation of drug prohibition policies in the U.S., which started in 1914 with the prohibition of alcohol.


Though Doctors and medical officials continue to call for a reclassification of the drug so they may study its therapeutic benefits, the federal supplier of medical grade cannabis, the National Institute on Drug Abuse (NIDA) isn't so keen to move its supply in this direction. For more information on the obstacles that Doctors who wish to study marijuana's medicinal benefits face, click the links below.






Recommended Comments

There are no comments to display.

Add a comment...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...